Quality

Cleanrooms Are Not Required for Cell Therapy Collection
Management & Regulatory Cleanrooms Are Not Required for Cell Therapy Collection

The biotechnology landscape in 2026 continues to grapple with the perceived necessity of high-classification cleanrooms for the collection of allogeneic starting materials, despite substantial evidence to the contrary. For years, the industry has operated under a pervasive assumption that the air

National Resilience Moves Headquarters to Southwest Ohio
Management & Regulatory National Resilience Moves Headquarters to Southwest Ohio

The geographical center of gravity for the American biopharmaceutical industry has begun a noticeable shift away from traditional coastal strongholds toward the industrial heartland of the United States. National Resilience, Inc. recently signaled a monumental change in its corporate identity by

Can Stewardship Capital Balance Profit and Patient Care?
Management & Regulatory Can Stewardship Capital Balance Profit and Patient Care?

The fundamental architecture of healthcare delivery is currently undergoing a radical transformation as the traditional friction between private capital's demand for high-speed returns and the sacred necessity of patient well-being reaches a critical breaking point. For several decades, the influx

WAHO Receives $14.26 Million to Bolster West African Health
Management & Regulatory WAHO Receives $14.26 Million to Bolster West African Health

The regional landscape of healthcare across West Africa is currently undergoing a significant transformation as international partners and regional bodies collaborate to address long-standing vulnerabilities in medical infrastructure and emergency response capabilities. This recent infusion of

Why Is the VA Failing to Hold Unsafe Doctors Accountable?
Management & Regulatory Why Is the VA Failing to Hold Unsafe Doctors Accountable?

A veteran walking into a Department of Veterans Affairs medical center expects the highest standard of care, yet recent investigations suggest that the administrative safeguards designed to protect them are fundamentally broken. The Department of Veterans Affairs faces intense scrutiny as audits

Can BSI PAS 2090 Standardize Pharmaceutical Sustainability?
Management & Regulatory Can BSI PAS 2090 Standardize Pharmaceutical Sustainability?

The pharmaceutical industry has long operated under a cloud of opaque environmental reporting that made it virtually impossible for healthcare providers to distinguish between truly green products and mere corporate marketing. Since the introduction of BSI PAS 2090 in late 2025, a standardized

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later